NovoCure Ltd (NVCR) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for NovoCure Ltd (NVCR): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 42/100 — a percentile rank of NovoCure Ltd’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $1.9B |
| P / S | 2.6× |
| EV / EBITDA | -14.2× |
| Gross margin | 76.1% |
| Operating margin | -22.1% |
| Net margin | -21.2% |
| Return on equity | -43.9% |
| ROIC | -34.1% |
| Revenue growth | 11.0% |
| Debt / equity | 0.6× |
| Dividend yield | 0.0% |
Is NovoCure Ltd overvalued? P/S looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from NovoCure Ltd’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact